A Schematic of the Vaccination Schedule Used to Treat MCL Patients in the Phase I/II Trial (IMAGE)

Rockefeller University Press

A Schematic of the Vaccination Schedule Used to Treat MCL Patients in the Phase I/II Trial

Caption

A schematic of the vaccination schedule used to treat MCL patients in the phase I/II trial. ASCT stands for autologous stem cell transplantation.

Credit

Frank et al., 2020

Usage Restrictions

Reporters may freely use these materials in news coverage with the appropriate credit information.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.